Study of the Impact of Trans Fatty Acids From Dairy Products on Cardiovascular Risk Factors
TRANS
1 other identifier
interventional
48
1 country
1
Brief Summary
The majority of trans fatty acids consumed by the general population is derived from products that have been formulated using significant amount of hydrogenated vegetable oil (the so-called industrial trans fat). Fat from ruminants also contains small amounts of trans fatty acid, which contribute, although to a smaller extent, to the total dietary intake of trans fatty acids in the general population. The negative impact of consuming industrial trans fat on health, particularly on cardiovascular disease, is being increasingly recognized. Based on data available to date, it is currently not possible to conclude if effects of ruminants and industrial trans fatty acid on cardiovascular risk are different. There is therefore an urgent need for a study that compares the impact of naturally occurring trans fatty acids such as those from dairy products and of trans fatty acids form industrial sources on cardiovascular risk factors as well as their mechanisms of action. The general objective of the study is to investigate the impact of naturally occurring trans fatty acids from dairy products (mainly vaccenic acid) on plasma cholesterol levels and other risk factors for cardiovascular disease.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started May 2006
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2006
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2007
CompletedStudy Completion
Last participant's last visit for all outcomes
November 1, 2007
CompletedFirst Submitted
Initial submission to the registry
July 9, 2010
CompletedFirst Posted
Study publicly available on registry
July 15, 2010
CompletedFebruary 11, 2011
July 1, 2010
1.2 years
July 9, 2010
February 10, 2011
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Plasma LDL-Cholesterol concentrations
At the beginning and the end of the 4 for-week diets
Secondary Outcomes (5)
Blood lipids and apolipoproteins levels (Total cholesterol, HDL-Cholesterol, Triglycerides, Apo A1, Apo B)
At the beginning and the end of the 4 for-week diets
Markers of inflammation (C-reactive protein)
At the beginning and the end of the 4 for-week diets
Blood pressure
At the beginning and the end of the 4 for-week diets
Anthropometric measures (waist and hip circumferences)
At the beginning and the end of the 4 for-week diets
Surrogates of cholesterol absorption and synthesis
At the beginning and the end of the 4 for-week diet
Interventions
Consumption of the 4 experimental diets: 1. a diet rich in ruminant TFA (8 g/day); 2. a diet moderately rich in ruminant TFA (4 g/day); 3. a diet rich in industrial TFA (8 g/d); 4. a control diet (minimal dietary TFA of industrial and ruminant sources).
Eligibility Criteria
You may qualify if:
- Healthy men
- LDL-Cholesterol concentration \<3.4 mmol/L
- Stable body weight (+/- 2 kg) for 6 months before the beginning of the study
- Smoking or not
You may not qualify if:
- Previous history of cardiovascular disease, type 2 diabetes and monogenic dyslipidemia
- Subjects taking medications for hyperlipidemia or hypertension
- Endocrine disorders
- Body mass index \> 30 kg/m2
- Food allergies
- Men with extreme nutritional habits such as vegetarism or alcohol consumption \> 2 drinks/day
- Elite athletes
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Laval Universitylead
- Dairy Farmers of Canadacollaborator
- Novalait Inccollaborator
Study Sites (1)
Institute of Nutraceutical and Functional Foods (INAF), Laval University
Québec, Quebec, G1V 0A6, Canada
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Benoît Lamarche, PhD
Laval University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
July 9, 2010
First Posted
July 15, 2010
Study Start
May 1, 2006
Primary Completion
July 1, 2007
Study Completion
November 1, 2007
Last Updated
February 11, 2011
Record last verified: 2010-07